SOPHiA GENETICS Hits Milestone of One Million Genomic Profiles Analyzed by the SOPHiA DDM™ Platform
BOSTON and LAUSANNE, Switzerland, April 26, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, has reached the milestone of one million genomic profiles analyzed by its SOPHiA DDM™ Platform, securing its position as one of the largest knowledge sharing platforms connecting thousands of healthcare professionals and researchers across more than...
Holmusk Announces Publication of Seminal Paper on Real-World Evidence (RWE) Platform NeuroBlu
NEW YORK, April 26, 2022 /PRNewswire/ -- Holmusk, a leading global data science and health technology company building the world's largest real-world evidence (RWE) platform for behavioral health, is pleased to share with the scientific community in-depth details about its platform via the publication of a paper in BMJ Open. The publication centers on the dataset available within NeuroBlu,...
SonoScape S-Fetus 4.0 Release to Simplify Sonography Process
SHENZHEN, China, April 26, 2022 /PRNewswire/ -- SonoScape Medical Corp. today announced the release of S-Fetus 4.0, the latest software upgrade of the company's flagship ultrasound product offering. This technical breakthrough marks S-Fetus 4.0 as the globally first smart obstetric screening technology based on deep learning. SonoScape S-Fetus 4.0 Obstetric Screening Assistant Leveraging the deep learning techniques,...
Octapharma to address unmet needs in von Willebrand disease as a proud sponsor of WFH 2022 World Congress
LACHEN, Switzerland, April 26, 2022 /PRNewswire/ -- As part of its ongoing commitment to the global bleeding disorders community, Octapharma is pleased to be a Gold Sponsor of the upcoming World Federation of Haemophilia (WFH) 2022 World Congress, taking place from May 8 to 11, 2022. This continues Octapharma's long history of...
Getinge Interim Report January-March 2022: Healthy order book but supply chain challenges
GOTHENBURG, Sweden, April 26, 2022 /PRNewswire/ -- "Net sales declined by 6.4% and the order intake fell organically by 4.4% in the quarter," says Mattias Perjos, President & CEO. "However, excluding the strong sales of ventilators in 2021, we had organic growth in both order intake and net sales. The order book grew 8% during the quarter and is 21%...
Ubie, Japanese HealthTech Startup, Launches AI-powered Symptom Checker in U.S.
- Trusted by 4.5 Million Monthly Users Worldwide - TOKYO and SINGAPORE, April 26, 2022 /PRNewswire/ -- Ubie, Inc., a healthcare AI startup with the mission "To develop a healthcare guide for everyone," has launched in the United States an "AI-powered symptom checker" ( https://ubiehealth.com ) that allows users to enter symptoms and discover related diseases. Image:https://kyodonewsprwire.jp/prwfile/release/M107009/202204180106/_prw_PI1fl_e08qVvYw.png Ubie, founded in Japan...
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress: Tracking hormonal pathways linking stress with reproductive dysfunction and failure
SINGAPORE, April 26, 2022 /PRNewswire/ -- Advanced insights into the potential impacts of stress on human reproductive health will be reported at the 2022 Congress of the Asia Pacific Initiative on Reproduction (ASPIRE) starting on Thursday. The Congress will hear of profound interaction between chronic and sustained stress and hormones, including those influencing...
Link Presents ‘Clean Living’ E-stamping Reward
Whilst supporting the latest round of Consumption Voucher Scheme, Link is creating a safe environment for shoppers and extending healthcare awareness to households Customers who use e-payment to spend at 14 of Link's shopping malls and fresh markets may redeem for Panasonic Anti-bacterial Smart Appliances HONG KONG, April 26, 2022 /PRNewswire/ -- Link launches the 'Clean Living'...
Volition Launches its Nu.Q® Vet Cancer Test in Asia Through its Appointed Distributor SAGE Healthcare
AUSTIN, Texas, April 25, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose and monitor a range of cancers and other life-altering diseases in both humans and animals, has announced the launch of its Nu.Q® Vet Cancer Test in Asia through its appointed...
DetectedX and GE Healthcare Enter Mammography Education Partnership to Improve Accuracy and Better Inform Clinical Decisions
Radiology Online Learning Centre from DetectedX – Available as Part of the GE Healthcare Clinical Education Program – Has Shown a 34% Improvement in the Accuracy of Diagnosing Difficult Cases SYDNEY, April 25, 2022 /PRNewswire/ -- Fostering global excellence in diagnostic accuracy, DetectedX and GE Healthcare have entered into an educational partnership to expand access to the Radiology Online...
